Biogen (BIIB) weekly IV elevated into EPS and new product timeline outlook
Biogen (NASDAQ: BIIB) April weekly call option implied volatility is at 112, May is at 62; compared to its 52-week range of 25 to 63 into the expected release of quarter results before the bell on April 22.
